Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2025 Earnings Call Transcript November 10, 2025
Akebia Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.00197, expectations were $-0.02.
Operator: Good day, and thank you for standing by. Welcome to Akebia’s Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Mercedes Carrasco,...
